Mayfair Gold wins Ontario fast-track permitting status for Fenn-Gib as C$310m financing plans advance
Read More Pharma Industry News GENFIT begins phase 3 trial of elafibranor in primary biliary cholangitis GENFIT has started the phase 3 ELATIVE clinical trial for evaluating the efficacy and safety of elafibranor for… bypharmanewsdailySeptember 25, 2020